Current & Critical - Stephen Van Deventer, Cannabis & BioTech - An Insider's POV

Investors investing in pharmaceuticals can be nervous about the lengthy process from R&D to commercialization and the regulatory approval processes. PreveCeuticals has diversified its research into four unique applications, which include three that have already been proven. Stephen took a bold approach of researching multiple solutions at once - something that can make investors feel a bit nervous. Stephen wants to develop treatments for major global medical issues like the opioid epidemic in Canada, and he knows exploring multiple projects at once is a faster way to do just that. Learn more about how to commercialize and invest in pharmaceuticals, particularly ‘fringe’ medicines such as cannabis.